| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |